Jung Melita Sun has filed 4 insider transactions across 2 companies since February 2023.
Most recent transaction: a purchase of 2250 shares of Terns Pharmaceuticals, Inc. ($TERN) on November 30, 2024.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 30, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Jung Melita Sun | Chief Business Officer | P | Common Stock | 2250 | $5.11 | 2,250.0000 | 77,819,658 | 9999.99% | 0.00% |
| Jan. 30, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Jung Melita Sun | Chief Business Officer | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 79,507,474 | 9999.99% | 0.41% |
| May 1, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Jung Melita Sun | Chief Business Officer | A | Stock Option (Right to buy) | 475000 | $0.00 | 475,000.0000 | 71,259,239 | 9999.99% | 0.67% |
| Feb. 7, 2023 | Structure Therapeutics Inc. | $GPCR | Jung Melita Sun | Chief Business Officer | P | American Depositary Shares | 1000 | $15.00 | 1,000.0000 | 9,584,000 | 9999.99% | 0.01% |